New weekly shot shows promise in fighting obesity

NCT ID NCT06595238

Completed Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study tested whether a new weekly injection called AZD6234 helps people with obesity or overweight lose weight. About 262 adults received either the drug or a placebo (dummy injection) for 36 weeks. The main goal was to see if the drug led to better weight loss results compared to the placebo.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Mobile, Alabama, 36608, United States
Research Site

Phoenix, Arizona, 85044, United States
Research Site

Long Beach, California, 90815, United States
Research Site

Hialeah, Florida, 33012, United States
Research Site

Largo, Florida, 33777, United States
Research Site

Orlando, Florida, 32825, United States
Research Site

Tampa, Florida, 33606, United States
Research Site

Woodstock, Georgia, 30189, United States
Research Site

Indianapolis, Indiana, 46260, United States
Research Site

Lutherville-Timonium, Maryland, 21093, United States
Research Site

Gulfport, Mississippi, 39503, United States
Research Site

Ridgeland, Mississippi, 39157, United States
Research Site

Kansas City, Missouri, 64111, United States
Research Site

Omaha, Nebraska, 68134, United States
Research Site

Portsmouth, New Hampshire, 03801, United States
Research Site

Statesville, North Carolina, 28625, United States
Research Site

North Charleston, South Carolina, 29405, United States
Research Site

Knoxville, Tennessee, 37938, United States
Research Site

Austin, Texas, 78731, United States
Research Site

Dallas, Texas, 75230, United States
Research Site

Port Arthur, Texas, 77642, United States
Research Site

San Antonio, Texas, 78231, United States
Research Site

San Antonio, Texas, 78249, United States
Research Site

Heidelberg, 3081, Australia
Research Site

Maroochydore, 4556, Australia
Research Site

Maroubra, 2035, Australia
Research Site

Merewether, 2291, Australia
Research Site

Hamilton, Ontario, L8L 5G8, Canada
Research Site

Sarnia, Ontario, N7T 4X3, Canada
Research Site

Stouffville, Ontario, L4A1H2, Canada
Research Site

Toronto, Ontario, M3J 2C5, Canada
Research Site

Montreal, Quebec, H4N 2W2, Canada
Research Site

Sherbrooke, Quebec, J1L 0H8, Canada
Research Site

Chūōku, 103-0027, Japan
Research Site

Chūōku, 104-0031, Japan
Research Site

Shinjuku-ku, 160-0008, Japan
Research Site

Suita-shi, 565-0853, Japan
Research Site

Hull, HU3 2PA, United Kingdom
Research Site

Leicester, Le5 4PW, United Kingdom
Research Site

Penarth, CF64 2XX, United Kingdom
Research Site

Rotherham, S65 1DA, United Kingdom

Conditions

Explore the condition pages connected to this study.

OBESITY OR OVERWEIGHT